What is the Nifty Pharma Index value today?
The latest value of Nifty Pharma Index is 26479.55 as of 10th August 2026.What is the shareholder returns of Nifty Pharma Index Index?
The Nifty Pharma Index has given the following returns in the past:- Past 1 week | -1.07%
- Past 1 month | 3.11%
- Past 3 months | 9.87%
- Past 6 months | 19.27%
- Past 1 year | 22.62%
- Past 3 years | 70.02%
- Past 5 years | 82.66%
What is the 52 week high value of Nifty Pharma Index?
The 52 week high value of Nifty Pharma Index is 26801.20, as of 10th August 2026.What is the 52 week low value of Nifty Pharma Index?
The 52 week low value of Nifty Pharma Index is 21149.90, as of 10th August 2026.What are the components of Nifty Pharma Index?
The components of Nifty Pharma Index, along with their weightage, are as follows -- Sun Pharmaceutical Industries Ltd | 21.46%
- Divi's Laboratories Ltd | 10.96%
- Cipla Ltd | 8.46%
- Torrent Pharmaceuticals Ltd | 7.11%
- Laurus Labs Ltd | 7.06%
Nifty Pharma Index Today
NIFTY PHARMA Share Price
ETFs tracking NIFTY PHARMA
NIFTY PHARMA Performance & Key Metrics
NIFTY PHARMA Performance & Key Metrics
| PE RatioPE Ratio | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 39.03 | 5.38 | 0.60% |
| Market Cap ShareM Cap Share | ConstituentsConstituents | ETFsETFs |
|---|---|---|
| 4.16% | 20 | 1 |
About NIFTY PHARMA
About NIFTY PHARMA
Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. The rescheduling of index constituents happens bi-annually every year.
Get more out of Tickertape, Go Pro!
Unlock exclusive stocks’ data & unlimited access with Tickertape Pro
Free float marketcap values in ₹ thousand cr.
| Stocks | 1D change | Return attribution | Index weight | Free float marketcap | |
|---|---|---|---|---|---|
| NIFTY PHARMA 1D return-0.20% | 0.20% | -0.20% | 100.00% | Free float Mcap964.98 Weight100.00% | |
ABBOTINDIA 1.08% Return attribution-0.02% | 1.08% | -0.02% | 1.48% | 14.31 Weight1.48% | |
AJANTPHARM 0.49% Return attribution0.01% | 0.49% | 0.01% | 1.65% | 15.96 Weight1.65% | |
ALKEM 0.38% Return attribution-0.01% | 0.38% | -0.01% | 2.61% | 25.14 Weight2.61% | |
AUROPHARMA 0.60% Return attribution-0.03% | 0.60% | -0.03% | 4.44% | 42.87 Weight4.44% | |
BIOCON 0.06% Return attribution-0.00% | 0.06% | -0.00% | 3.65% | 35.26 Weight3.65% | |
ZYDUSLIFE 0.33% Return attribution0.01% | 0.33% | 0.01% | 2.87% | 27.70 Weight2.87% | |
CIPLA 0.27% Return attribution0.02% | 0.27% | 0.02% | 8.46% | 81.67 Weight8.46% | |
DIVISLAB 0.30% Return attribution0.03% | 0.30% | 0.03% | 10.96% | 105.76 Weight10.96% | |
DRREDDY 1.13% Return attribution-0.08% | 1.13% | -0.08% | 7.03% | 67.80 Weight7.03% | |
Glenmark Pharmaceuticals Limited GLENMARK 1.22% Return attribution-0.04% | 1.22% | -0.04% | 3.36% | 32.43 Weight3.36% | |
IPCALAB 2.88% Return attribution-0.07% | 2.88% | -0.07% | 2.44% | 23.50 Weight2.44% | |
LAURUSLABS 0.53% Return attribution0.04% | 0.53% | 0.04% | 7.06% | 68.09 Weight7.06% | |
LUPIN 2.69% Return attribution-0.16% | 2.69% | -0.16% | 5.77% | 55.71 Weight5.77% | |
Sun Pharmaceutical Industries Ltd SUNPHARMA 0.14% Return attribution0.03% | 0.14% | 0.03% | 21.46% | 207.10 Weight21.46% | |
TORNTPHARM 0.49% Return attribution-0.03% | 0.49% | -0.03% | 7.11% | 68.66 Weight7.11% | |
WOCKPHARMA 4.40% Return attribution-0.07% | 4.40% | -0.07% | 1.59% | 15.37 Weight1.59% | |
GLAND 2.55% Return attribution0.06% | 2.55% | 0.06% | 2.20% | 21.22 Weight2.20% | |
PPLPHARMA 1.82% Return attribution0.02% | 1.82% | 0.02% | 1.33% | 12.87 Weight1.33% | |
MANKIND 0.73% Return attribution-0.02% | 0.73% | -0.02% | 2.57% | 24.77 Weight2.57% | |
SAILIFE 5.18% Return attribution0.10% | 5.18% | 0.10% | 1.95% | 18.79 Weight1.95% |
ETFs tracking NIFTY PHARMA Index
ETFs tracking NIFTY PHARMA Index
| ETFs | Price | Liquidity | Expense ratio | Tracking error | |
|---|---|---|---|---|---|
PHARMABEES — | — | High | 0.21% | 0.02% |
NIFTY PHARMA Events
NIFTY PHARMA Events
Dividends
Corp. Actions
Announcements
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
NIFTY PHARMA Upcoming Dividends
NIFTY PHARMA Upcoming Dividends
Cash DividendGLENMARK
GLENMARKEx DateEx DateAug 31, 2026
Dividend/Share
₹2.50
Ex DateEx Date
Aug 31, 2026
Cash DividendGLAND
GLANDEx DateEx DateAug 11, 2026
Dividend/Share
₹20.00
Ex DateEx Date
Aug 11, 2026
NIFTY PHARMA Past Dividends
NIFTY PHARMA Past Dividends
Cash DividendALKEM
ALKEMEx DateEx DateAug 7, 2026
Dividend/Share
₹10.00
Ex DateEx Date
Aug 7, 2026
Cash DividendIPCALAB
IPCALABEx DateEx DateAug 7, 2026
Dividend/Share
₹6.00
Ex DateEx Date
Aug 7, 2026
Cash DividendAJANTPHARM
AJANTPHARMEx DateEx DateAug 5, 2026
Dividend/Share
₹32.00
Ex DateEx Date
Aug 5, 2026
Cash DividendABBOTINDIA
ABBOTINDIAEx DateEx DateJul 24, 2026
Dividend/Share
₹131.00
Ex DateEx Date
Jul 24, 2026
Cash DividendABBOTINDIA
ABBOTINDIAEx DateEx DateJul 24, 2026
Dividend/Share
₹525.00
Ex DateEx Date
Jul 24, 2026
NIFTY PHARMA News & Opinions
NIFTY PHARMA News & Opinions
Independence Day 2026: India, which once couldn’t make smallpox vaccine, has now crossed a pharma milestone the world can’t ignore
10 hours ago•Economic Times
RGUHS becomes first government university to unveil revised BPharm syllabus
2 days ago•The Hindu
India’s exports from SEZs up 11.8% in 2025-26: Govt
6 days ago•Economic Times
India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body says
6 days ago•Economic Times
Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
1 week ago•The Hindu Businessline
How AI is helping pharma prevent drug recalls, counter fakes and improve patient safety - The Economic Times
1 week ago•Economic Times
US tariff proposal wake-up call for Indian pharma to diversify, innovate: Experts
2 weeks ago•The Hindu Businessline
Make Telangana safest manufacturing location, official tells pharma industry
2 weeks ago•The Hindu
Sensex, Nifty slide at open as West Asia crisis drives oil above $95; Dr Reddy’s drags pharma
2 weeks ago•The Hindu Businessline
Fostering new opportunities in the Greater Bay Area and Asia’s Pharmaceutical Industry
2 weeks ago•The Hindu Businessline